Debra Howell

Professor of Health Services Research, Epidemiology & Cancer Statistics Group, Qualitative lead, Patient and Public Involvement lead, blood cancer experiences

[YHHN_UK @YHHN_UK]

Lovely to meet with patients and relatives at @ECSG_UoY's PPI workshop yesterday. Their views on the future direction of our research, based on their own experiences, were amazing. Great also to catch up with PPI colleagues from @InvolvementYork, @CBR_UoY and @LeedsBRC.

[YHHN_UK @YHHN_UK]

Research is Beautiful – the best of the rest https://t.co/k1WWEqnS4c Great to see our Open Day for patients with blood cancer and their families featured here...

[NIHR Leeds BRC @LeedsBRC]

We're seeking an Academic Capacity Development Co-Lead in executing our ACD strategy. Only open to colleagues from BRC partner organisations, but you do not need to be currently associated with BRC to apply.
👉 https://t.co/JpBIXVbsEc
@UniversityLeeds @LTHTResearch @UniOfYork

[LymphomaAction @LymphomaAction]

Two weeks to go until our free in-person Live your Life workshop in Cardiff! @CAVUHB

Join us to connect with others and find local help and support 💜

https://t.co/H0tgJeNQyT

#Lymphoma #LymphomaCancer #BloodCancer #LymphomaAwareness #LymphomaSupport #LymphomaMatters

[Blood Cancer UK Research @BloodCancer_Res]

Final chance to submit an EOI to the #OurFutureHealth Early Adopters Scheme as a Research Ambassador or Research Scholar, deadline Friday 3rd May. Representation still needed from those working in rare diseases, drug discovery, medical devices & screening https://t.co/HWmDwykgDV

[Leukaemia Care @LeukaemiaCareUK]

Join us at @BritSocHaem! We're excited to discuss the latest in leukaemia updates, patient services, and our newest e-learning courses.
Come and meet our team at stand CP13!👋
@scicommchar

[Blood Cancer UK Research @BloodCancer_Res]

We’re exhibiting at @BritSocHaem, come say hello at stand CP1 👋🏽
#BSH24

[Debra Howell @Debra_Howell67]

Interested in Patient and Public Involvement in multiple myeloma trials? Get involved here:
https://t.co/QCTKgW8Fvh

[National Non-Hodgkin Lymphoma Audit (NNHLA) @NNHLA_NATCAN]

Check out the latest updates from the National Non- Hodgkin Lymphoma Audit (NNHLA) team👀🔍
https://t.co/jHzlAc6ACm
@NATCAN_news @HQIP @LymphomaAction @bloodcancer_uk @BloodJournal @BritSocHaem @RCRadiologists @LLSusa @HaemSTAR_UK @DavidJCutter @OxfordHaem @YHHN_UK @AnthonyNolan

[International Myeloma Foundation @IMFmyeloma]

Join Jerry and Jill as they delve into the journey of living with myeloma, from the initial confusion of diagnosis to exploring treatment options like CAR T-cell therapy. Thank you to @thebindingsite for supporting these patient stories. https://t.co/8tnofmtXSh

[Cancer Research UK @CR_UK]

Spotting cancer at an early stage means that treatment is more likely to be successful, so if you notice something that’s not normal for you, contact your doctor. In most cases, it won’t be cancer — but if it is, finding it early can make all the difference. Find out more �Spotting cancer at an early stage means that treatment is more likely to be successful, so if you notice something that’s not normal for you, contact your doctor. In most cases, it won’t be cancer — but if it is, finding it early can make all the difference. Find out more �Spotting cancer at an early stage means that treatment is more likely to be successful, so if you notice something that’s not normal for you, contact your doctor. In most cases, it won’t be cancer — but if it is, finding it early can make all the difference. Find out more 👇

[Macmillan Cancer Support @macmillancancer]

As His Majesty The King returns to public-facing duties, we know many people with cancer will understand that choosing to return to work can be a complex decision and can mean very different things to different people.

[Blood Cancer UK Research @BloodCancer_Res]

If you’re at BSH today, please join the top abstract session presented by our Ambassador Mel, he will share his experience of living with CLL and the importance raising awareness of blood cancer👇🏽
#BSH24 #BSH2024

[York Medical Society @york_med_soc]

Prof Eve Roman @evearoman @UniOfYork is telling us about the haematological malignancy research network and the superb research outputs from this.

[HMRN UK @HMRN_UK]

When a Cure Isn’t an Option https://t.co/UOYDaBc5FT. Including contributions from HMRN's Debra Howell and Russell Patmore. Citing findings from our study examining the the impact on patients diagnosed with a chronic blood cancer https://t.co/tVvcYPYpZ1 @bloodcancer_uk

[HMRN UK @HMRN_UK]

More information on the incidence & prevalence of blood cancers can be found on our website https://t.co/zjoL7C4Dmt. Although collectively blood cancers are the fifth most common cancer group diagnosed in the UK, many types affect few than 1 in 2,000 people #RareDiseaseDay

[HMRN UK @HMRN_UK]

Great summary of our recent paper published in Cancer Epidemiology!
Registry reveals diversity of lymphoid blood cancers: https://t.co/757x4qhX27
https://t.co/xEORvpZxXV
@thelimbichaemUK @CancerEpid

[Hull York Medical School @HullYorkMed]

Today we're showcasing some of the innovative and creative research projects that are part of the TRANSFORMing Cancer Outcomes in Yorkshire programme – or ‘TRANSFORM'. This £4.9m programme, funded by @yorkshirecancer, aims to tackle cancer inequalities and improve health outcomes

[Centre for Blood Research @CBR_UoY]

@ECSG_UoY @HMRN_UK are hosting a Blood Cancer Research open day Saturday 28 October 2023.

A day for patients, families & clinicians to meet up, share their experiences & shape our research into blood cancers.

For more information & to register: https://t.co/FzcJlpataj

[HMRN UK @HMRN_UK]

Morning session of our Blood Cancer Research Open day is in full swing with talks from Russell Patmore, Debra Howell and Bob Phillips @CBR_UoY @UniOfYork @YHHN_UK @CR_UK @bloodcancer_uk